Logo image of BH.A

BIGLARI HOLDINGS INC-A (BH.A) Stock Fundamental Analysis

NYSE:BH.A - New York Stock Exchange, Inc. - US08986R4083 - Common Stock - Currency: USD

1055.89  -9.61 (-0.9%)

Fundamental Rating

4

Taking everything into account, BH.A scores 4 out of 10 in our fundamental rating. BH.A was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. While BH.A has a great health rating, its profitability is only average at the moment. BH.A does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year BH.A was profitable.
BH.A had a positive operating cash flow in the past year.
In multiple years BH.A reported negative net income over the last 5 years.
Each year in the past 5 years BH.A had a positive operating cash flow.
BH.A Yearly Net Income VS EBIT VS OCF VS FCFBH.A Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.91%, BH.A is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
With a decent Return On Equity value of 8.50%, BH.A is doing good in the industry, outperforming 65.93% of the companies in the same industry.
BH.A has a worse Return On Invested Capital (2.76%) than 68.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BH.A is significantly below the industry average of 16.11%.
Industry RankSector Rank
ROA 5.91%
ROE 8.5%
ROIC 2.76%
ROA(3y)2.18%
ROA(5y)1.36%
ROE(3y)3.1%
ROE(5y)1.99%
ROIC(3y)4.8%
ROIC(5y)3.64%
BH.A Yearly ROA, ROE, ROICBH.A Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 14.14%, BH.A belongs to the top of the industry, outperforming 84.44% of the companies in the same industry.
BH.A's Profit Margin has improved in the last couple of years.
BH.A has a Operating Margin of 6.70%. This is comparable to the rest of the industry: BH.A outperforms 42.22% of its industry peers.
BH.A's Operating Margin has improved in the last couple of years.
BH.A's Gross Margin of 39.32% is on the low side compared to the rest of the industry. BH.A is outperformed by 62.96% of its industry peers.
BH.A's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.7%
PM (TTM) 14.14%
GM 39.32%
OM growth 3Y18.21%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y44.41%
GM growth 3Y10.42%
GM growth 5Y18.32%
BH.A Yearly Profit, Operating, Gross MarginsBH.A Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BH.A is destroying value.
BH.A has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BH.A has been reduced compared to 5 years ago.
BH.A has a better debt/assets ratio than last year.
BH.A Yearly Shares OutstandingBH.A Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
BH.A Yearly Total Debt VS Total AssetsBH.A Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 7.10 indicates that BH.A is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.10, BH.A belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
The Debt to FCF ratio of BH.A is 3.05, which is a good value as it means it would take BH.A, 3.05 years of fcf income to pay off all of its debts.
BH.A has a better Debt to FCF ratio (3.05) than 80.00% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that BH.A is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, BH.A belongs to the top of the industry, outperforming 83.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.05
Altman-Z 7.1
ROIC/WACC0.3
WACC9.1%
BH.A Yearly LT Debt VS Equity VS FCFBH.A Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

BH.A has a Current Ratio of 1.47. This is a normal value and indicates that BH.A is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.47, BH.A is doing good in the industry, outperforming 71.11% of the companies in the same industry.
BH.A has a Quick Ratio of 1.44. This is a normal value and indicates that BH.A is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.44, BH.A is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.44
BH.A Yearly Current Assets VS Current LiabilitesBH.A Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

BH.A shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.91%, which is quite impressive.
Measured over the past years, BH.A shows a very strong growth in Earnings Per Share. The EPS has been growing by 59.32% on average per year.
BH.A shows a decrease in Revenue. In the last year, the revenue decreased by -3.07%.
Measured over the past years, BH.A shows a very negative growth in Revenue. The Revenue has been decreasing by -14.72% on average per year.
EPS 1Y (TTM)260.91%
EPS 3YN/A
EPS 5Y59.32%
EPS Q2Q%158.69%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y-5.56%
Revenue growth 5Y-14.72%
Sales Q2Q%-0.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH.A Yearly Revenue VS EstimatesBH.A Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
BH.A Yearly EPS VS EstimatesBH.A Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.88 indicates a reasonable valuation of BH.A.
Based on the Price/Earnings ratio, BH.A is valued cheaper than 87.41% of the companies in the same industry.
BH.A is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.88
Fwd PE N/A
BH.A Price Earnings VS Forward Price EarningsBH.A Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BH.A indicates a slightly more expensive valuation: BH.A is more expensive than 75.56% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BH.A.
Industry RankSector Rank
P/FCF 92.6
EV/EBITDA 35.54
BH.A Per share dataBH.A EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BH.A does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIGLARI HOLDINGS INC-A

NYSE:BH.A (3/7/2025, 8:07:26 PM)

1055.89

-9.61 (-0.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-24 2025-02-24
Earnings (Next)05-08 2025-05-08
Inst Owners88.33%
Inst Owner Change3.44%
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap2.41B
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE N/A
P/S 6.66
P/FCF 92.6
P/OCF 43
P/B 4
P/tB 4.58
EV/EBITDA 35.54
EPS(TTM)88.86
EY8.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)11.4
FCFY1.08%
OCF(TTM)24.56
OCFY2.33%
SpS158.62
BVpS263.93
TBVpS230.67
PEG (NY)N/A
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 5.91%
ROE 8.5%
ROCE 3.22%
ROIC 2.76%
ROICexc 3.35%
ROICexgc 3.81%
OM 6.7%
PM (TTM) 14.14%
GM 39.32%
FCFM 7.19%
ROA(3y)2.18%
ROA(5y)1.36%
ROE(3y)3.1%
ROE(5y)1.99%
ROIC(3y)4.8%
ROIC(5y)3.64%
ROICexc(3y)5.72%
ROICexc(5y)4.33%
ROICexgc(3y)6.54%
ROICexgc(5y)4.95%
ROCE(3y)5.6%
ROCE(5y)4.25%
ROICexcg growth 3Y11.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y11.14%
ROICexc growth 5YN/A
OM growth 3Y18.21%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y44.41%
GM growth 3Y10.42%
GM growth 5Y18.32%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.05
Debt/EBITDA 1.16
Cap/Depr 76.72%
Cap/Sales 8.29%
Interest Coverage 250
Cash Conversion 88.4%
Profit Quality 50.83%
Current Ratio 1.47
Quick Ratio 1.44
Altman-Z 7.1
F-Score5
WACC9.1%
ROIC/WACC0.3
Cap/Depr(3y)118.64%
Cap/Depr(5y)96%
Cap/Sales(3y)10.7%
Cap/Sales(5y)7.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.91%
EPS 3YN/A
EPS 5Y59.32%
EPS Q2Q%158.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y-5.56%
Revenue growth 5Y-14.72%
Sales Q2Q%-0.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.63%
EBIT growth 3Y11.64%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.79%
FCF growth 3Y-20.01%
FCF growth 5Y76.45%
OCF growth 1Y-52.31%
OCF growth 3Y-14.69%
OCF growth 5Y28.67%